JP2004532223A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532223A5 JP2004532223A5 JP2002582927A JP2002582927A JP2004532223A5 JP 2004532223 A5 JP2004532223 A5 JP 2004532223A5 JP 2002582927 A JP2002582927 A JP 2002582927A JP 2002582927 A JP2002582927 A JP 2002582927A JP 2004532223 A5 JP2004532223 A5 JP 2004532223A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- spiro
- piperidine
- group
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 58
- -1 -CH 2 OH Chemical group 0.000 claims 45
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000000753 cycloalkyl group Chemical group 0.000 claims 21
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 125000001424 substituent group Chemical group 0.000 claims 16
- 125000003118 aryl group Chemical group 0.000 claims 15
- 150000002367 halogens Chemical class 0.000 claims 15
- 125000003545 alkoxy group Chemical group 0.000 claims 14
- 239000001257 hydrogen Substances 0.000 claims 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- 150000002431 hydrogen Chemical group 0.000 claims 10
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 8
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 125000003282 alkyl amino group Chemical group 0.000 claims 7
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000004043 oxo group Chemical group O=* 0.000 claims 5
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 4
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000002950 monocyclic group Chemical group 0.000 claims 4
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 2
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- PNULDNFMKQSJDK-UHFFFAOYSA-N 1'-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C12=CC=CC=C2CCC11CCN(C2CC3CCCCC3CC2)CC1 PNULDNFMKQSJDK-UHFFFAOYSA-N 0.000 claims 1
- RNXPWRGCFBJEBC-UHFFFAOYSA-N 1'-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)spiro[indene-1,4'-piperidine] Chemical compound C1=CC2=CC=CC=C2C1(CC1)CCN1C1CC2CCCCC2CC1 RNXPWRGCFBJEBC-UHFFFAOYSA-N 0.000 claims 1
- XQYSCVDRMWSQEL-UHFFFAOYSA-N 1'-(2,3-dihydro-1h-inden-2-yl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C12=CC=CC=C2CCC11CCN(C2CC3=CC=CC=C3C2)CC1 XQYSCVDRMWSQEL-UHFFFAOYSA-N 0.000 claims 1
- MPDHINFVEFHYFB-UHFFFAOYSA-N 1'-(2,3-dihydro-1h-inden-2-yl)spiro[indene-1,4'-piperidine] Chemical compound C1=CC2=CC=CC=C2C1(CC1)CCN1C1CC2=CC=CC=C2C1 MPDHINFVEFHYFB-UHFFFAOYSA-N 0.000 claims 1
- IZSOEQWAJSGUMC-UHFFFAOYSA-N 1'-(2-phenylethyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3CC2)CCN1CCC1=CC=CC=C1 IZSOEQWAJSGUMC-UHFFFAOYSA-N 0.000 claims 1
- LNMOBTPIDPUKDV-UHFFFAOYSA-N 1'-(3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-yl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound O1CC(C)(C)COC11CCC(N2CCC3(C4=CC=CC=C4CC3)CC2)CC1 LNMOBTPIDPUKDV-UHFFFAOYSA-N 0.000 claims 1
- YJGQGVFLPGUOQS-UHFFFAOYSA-N 1'-(3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-yl)spiro[indene-1,4'-piperidine] Chemical compound O1CC(C)(C)COC11CCC(N2CCC3(CC2)C2=CC=CC=C2C=C3)CC1 YJGQGVFLPGUOQS-UHFFFAOYSA-N 0.000 claims 1
- CKSLXVZSQPJDMO-UHFFFAOYSA-N 1'-(3,3-diphenylpropyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3CC2)CCN1CCC(C=1C=CC=CC=1)C1=CC=CC=C1 CKSLXVZSQPJDMO-UHFFFAOYSA-N 0.000 claims 1
- LJLKBUNRUSZMSI-UHFFFAOYSA-N 1'-(3,3-diphenylpropyl)spiro[indene-1,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3C=C2)CCN1CCC(C=1C=CC=CC=1)C1=CC=CC=C1 LJLKBUNRUSZMSI-UHFFFAOYSA-N 0.000 claims 1
- JUYHQLDPNTVZBQ-UHFFFAOYSA-N 1'-(3-bicyclo[2.2.1]heptanyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2=CC=CC=C2C1(CC1)CCN1C1CC2CC1CC2 JUYHQLDPNTVZBQ-UHFFFAOYSA-N 0.000 claims 1
- OSUBZFYIAFSCFG-UHFFFAOYSA-N 1'-(3-bicyclo[2.2.1]heptanyl)spiro[indene-1,4'-piperidine] Chemical compound C1=CC2=CC=CC=C2C1(CC1)CCN1C1CC2CC1CC2 OSUBZFYIAFSCFG-UHFFFAOYSA-N 0.000 claims 1
- YMFHWBXASJRUMY-UHFFFAOYSA-N 1'-(4-propan-2-ylcyclohexyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC(C(C)C)CCC1N1CCC2(C3=CC=CC=C3CC2)CC1 YMFHWBXASJRUMY-UHFFFAOYSA-N 0.000 claims 1
- VWFGAZKJOPTKMR-UHFFFAOYSA-N 1'-(4-propan-2-ylcyclohexyl)spiro[indene-1,4'-piperidine] Chemical compound C1CC(C(C)C)CCC1N1CCC2(C3=CC=CC=C3C=C2)CC1 VWFGAZKJOPTKMR-UHFFFAOYSA-N 0.000 claims 1
- KRPSXNNVCBQCEC-UHFFFAOYSA-N 1'-(4-propylcyclohexyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC(CCC)CCC1N1CCC2(C3=CC=CC=C3CC2)CC1 KRPSXNNVCBQCEC-UHFFFAOYSA-N 0.000 claims 1
- DEQOCEXKPGKZSN-UHFFFAOYSA-N 1'-(5-methylhexan-2-yl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CN(C(C)CCC(C)C)CCC11C2=CC=CC=C2CC1 DEQOCEXKPGKZSN-UHFFFAOYSA-N 0.000 claims 1
- LNOMOXRJKOWWGC-UHFFFAOYSA-N 1'-(5-methylhexan-2-yl)spiro[indene-1,4'-piperidine] Chemical compound C1CN(C(C)CCC(C)C)CCC21C1=CC=CC=C1C=C2 LNOMOXRJKOWWGC-UHFFFAOYSA-N 0.000 claims 1
- QOWJAEKTRKLYBG-UHFFFAOYSA-N 1'-(6,11-dihydro-5h-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C12=CC=CC=C2CCC2=CC=CC=C2C1N(CC1)CCC11CCC2=CC=CC=C21 QOWJAEKTRKLYBG-UHFFFAOYSA-N 0.000 claims 1
- HVSPQHTVYBVQHM-UHFFFAOYSA-N 1'-(6,11-dihydro-5h-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)spiro[indene-1,4'-piperidine] Chemical compound C12=CC=CC=C2CCC2=CC=CC=C2C1N1CCC2(C3=CC=CC=C3C=C2)CC1 HVSPQHTVYBVQHM-UHFFFAOYSA-N 0.000 claims 1
- XINKQWBLHGCLOJ-UHFFFAOYSA-N 1'-(7-bicyclo[2.2.1]heptanyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2=CC=CC=C2C1(CC1)CCN1C1C2CCC1CC2 XINKQWBLHGCLOJ-UHFFFAOYSA-N 0.000 claims 1
- BAJSEEKSPUDVGQ-UHFFFAOYSA-N 1'-(cyclooctylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3CC2)CCN1CC1CCCCCCC1 BAJSEEKSPUDVGQ-UHFFFAOYSA-N 0.000 claims 1
- PIAHAZASHUUYOH-UHFFFAOYSA-N 1'-(cyclooctylmethyl)spiro[indene-1,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3C=C2)CCN1CC1CCCCCCC1 PIAHAZASHUUYOH-UHFFFAOYSA-N 0.000 claims 1
- ZPDQZCRLHXPZRI-UHFFFAOYSA-N 1'-(naphthalen-1-ylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1=CC=C2C(CN3CCC4(C5=CC=CC=C5CC4)CC3)=CC=CC2=C1 ZPDQZCRLHXPZRI-UHFFFAOYSA-N 0.000 claims 1
- VAYBSXTUUZARGP-UHFFFAOYSA-N 1'-(naphthalen-1-ylmethyl)spiro[indene-1,4'-piperidine] Chemical compound C1=CC=C2C(CN3CCC4(CC3)C3=CC=CC=C3C=C4)=CC=CC2=C1 VAYBSXTUUZARGP-UHFFFAOYSA-N 0.000 claims 1
- KXMWVKLODWPLHK-UHFFFAOYSA-N 1'-(naphthalen-2-ylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1=CC=CC2=CC(CN3CCC4(C5=CC=CC=C5CC4)CC3)=CC=C21 KXMWVKLODWPLHK-UHFFFAOYSA-N 0.000 claims 1
- WTAUIAKKKYILAA-UHFFFAOYSA-N 1'-(naphthalen-2-ylmethyl)spiro[indene-1,4'-piperidine] Chemical compound C1=CC=CC2=CC(CN3CCC4(CC3)C3=CC=CC=C3C=C4)=CC=C21 WTAUIAKKKYILAA-UHFFFAOYSA-N 0.000 claims 1
- GSXJSGMDWKPVBY-UHFFFAOYSA-N 1'-(phenylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3CC2)CCN1CC1=CC=CC=C1 GSXJSGMDWKPVBY-UHFFFAOYSA-N 0.000 claims 1
- AANJKKDEXNNEKD-UHFFFAOYSA-N 1'-[(4-phenylmethoxyphenyl)methyl]spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C=1C=C(CN2CCC3(C4=CC=CC=C4CC3)CC2)C=CC=1OCC1=CC=CC=C1 AANJKKDEXNNEKD-UHFFFAOYSA-N 0.000 claims 1
- MWRSALXQUKNUKD-UHFFFAOYSA-N 1'-[(4-phenylmethoxyphenyl)methyl]spiro[indene-1,4'-piperidine] Chemical compound C=1C=C(CN2CCC3(CC2)C2=CC=CC=C2C=C3)C=CC=1OCC1=CC=CC=C1 MWRSALXQUKNUKD-UHFFFAOYSA-N 0.000 claims 1
- WOHHMRWQNDCZPA-UHFFFAOYSA-N 1'-[(4-phenylphenyl)methyl]spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3CC2)CCN1CC(C=C1)=CC=C1C1=CC=CC=C1 WOHHMRWQNDCZPA-UHFFFAOYSA-N 0.000 claims 1
- LVPJERPQXNELLP-UHFFFAOYSA-N 1'-[(4-phenylphenyl)methyl]spiro[indene-1,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3C=C2)CCN1CC(C=C1)=CC=C1C1=CC=CC=C1 LVPJERPQXNELLP-UHFFFAOYSA-N 0.000 claims 1
- YVXWZLBBLSRVOP-UHFFFAOYSA-N 1'-[4,4-bis(4-fluorophenyl)butyl]spiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC2(C3=CC=CC=C3CC2)CC1 YVXWZLBBLSRVOP-UHFFFAOYSA-N 0.000 claims 1
- JVQBWBKDYBNJLP-UHFFFAOYSA-N 1'-[4,4-bis(4-fluorophenyl)butyl]spiro[indene-1,4'-piperidine] Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC2(C3=CC=CC=C3C=C2)CC1 JVQBWBKDYBNJLP-UHFFFAOYSA-N 0.000 claims 1
- OQPGVLZDVOZJLJ-UHFFFAOYSA-N 1'-cyclodecylspiro[indene-1,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3C=C2)CCN1C1CCCCCCCCC1 OQPGVLZDVOZJLJ-UHFFFAOYSA-N 0.000 claims 1
- UTNYZWUCOISVME-UHFFFAOYSA-N 1'-cyclooctylspiro[1,2-dihydroindene-3,4'-piperidine] Chemical compound C12=CC=CC=C2CCC1(CC1)CCN1C1CCCCCCC1 UTNYZWUCOISVME-UHFFFAOYSA-N 0.000 claims 1
- URGFMBOYZAXORX-UHFFFAOYSA-N 1'-cyclooctylspiro[indene-1,4'-piperidine] Chemical compound C1CC2(C3=CC=CC=C3C=C2)CCN1C1CCCCCCC1 URGFMBOYZAXORX-UHFFFAOYSA-N 0.000 claims 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims 1
- YCDROFISSLEFEV-UHFFFAOYSA-N 4-(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylmethyl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1CN1CCC2(C3=CC=CC=C3CC2)CC1 YCDROFISSLEFEV-UHFFFAOYSA-N 0.000 claims 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 claims 1
- 241000790917 Dioxys <bee> Species 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28467001P | 2001-04-18 | 2001-04-18 | |
| PCT/US2002/012357 WO2002085354A1 (en) | 2001-04-18 | 2002-04-18 | Spiroindene and spiroindane compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004532223A JP2004532223A (ja) | 2004-10-21 |
| JP2004532223A5 true JP2004532223A5 (enExample) | 2005-12-22 |
| JP4489354B2 JP4489354B2 (ja) | 2010-06-23 |
Family
ID=23091075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002582927A Expired - Fee Related JP4489354B2 (ja) | 2001-04-18 | 2002-04-18 | スピロインデンおよびスピロインダン化合物類 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6828440B2 (enExample) |
| EP (2) | EP1385514B9 (enExample) |
| JP (1) | JP4489354B2 (enExample) |
| AT (1) | ATE413175T1 (enExample) |
| AU (1) | AU2002256282C1 (enExample) |
| CA (1) | CA2443938C (enExample) |
| CY (1) | CY1108731T1 (enExample) |
| DE (1) | DE60229736D1 (enExample) |
| DK (1) | DK1385514T5 (enExample) |
| ES (1) | ES2316559T3 (enExample) |
| PT (1) | PT1385514E (enExample) |
| SI (1) | SI1385514T1 (enExample) |
| WO (1) | WO2002085354A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
| JP2005519921A (ja) * | 2002-01-28 | 2005-07-07 | ファイザー株式会社 | Ｏｒｌ−１受容体リガンドとしてのｎ置換スピロピペリジン化合物 |
| ES2392340T3 (es) | 2002-03-29 | 2012-12-07 | Mitsubishi Tanabe Pharma Corporation | Remedio para los trastornos del sueño |
| BRPI0409078A (pt) | 2003-04-04 | 2006-04-18 | Merck & Co Inc | composto, métodos para o tratamento ou prevenção de distúrbios, doenças ou condições responsivas à ativação do receptor de melanocortina-4, para o tratamento ou prevenção de obesidade, para o tratamento ou prevenção de um distúrbio relacionado com a obesidade, para o tratamento ou prevenção de diabete melito, para o tratamento ou prevenção da disfunção sexual masculina ou feminina e para o tratamento ou prevenção de disfunção erétil, composição farmacêutica, métodos para o tratamento de disfução erétil em um mamìfero, para o tratamento de diabete em um mamìfero e para o tratamento de obesidade em um mamìfero, e, uso de um composto |
| GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
| US20100028339A1 (en) | 2004-03-29 | 2010-02-04 | Cheng Jin Q | Compositions including triciribine and trastuzumab and methods of use thereof |
| AU2005228410A1 (en) | 2004-03-29 | 2005-10-13 | University Of South Florida | Effective treatment of tumors and cancer with triciribine and related compounds |
| US20100009928A1 (en) | 2004-03-29 | 2010-01-14 | Cheng Jin Q | Compositions including triciribine and taxanes and methods of use thereof |
| BRPI0509307A (pt) | 2004-03-29 | 2007-09-04 | Pfizer | compostos de alfa aril ou heteroaril metil beta piperidino propanamida como antagonistas do receptor orl1 |
| US20100173864A1 (en) * | 2004-03-29 | 2010-07-08 | Cheng Jin Q | Compositions including triciribine and one or more platinum compounds and methods of use thereof |
| US20100009929A1 (en) | 2004-03-29 | 2010-01-14 | Cheng Jin Q | Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof |
| US20110008327A1 (en) | 2004-03-29 | 2011-01-13 | Cheng Jin Q | Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof |
| NZ553202A (en) * | 2004-08-19 | 2010-12-24 | Vertex Pharma | Modulators of muscarinic receptors |
| US7786141B2 (en) * | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| RU2007124373A (ru) * | 2004-11-29 | 2009-01-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецептеров |
| JP2009507800A (ja) | 2005-09-09 | 2009-02-26 | ユーロ−セルティーク エス．エイ． | 縮合およびスピロ環化合物ならびにその使用 |
| CN1870631B (zh) * | 2005-11-11 | 2010-04-14 | 华为技术有限公司 | 媒体网关的门控方法 |
| KR20080087841A (ko) * | 2005-12-22 | 2008-10-01 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린 수용체의 조절제 |
| WO2007100664A2 (en) | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2642649A1 (en) * | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| JP2009542670A (ja) * | 2006-06-29 | 2009-12-03 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
| US7696201B2 (en) * | 2006-08-15 | 2010-04-13 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2660974A1 (en) * | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| US20080051380A1 (en) | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
| TWI448289B (zh) | 2007-08-31 | 2014-08-11 | Purdue Pharma Lp | 經取代之喹啉型哌啶化合物及其用途 |
| CA2700724A1 (en) * | 2007-10-03 | 2009-04-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| JP5451646B2 (ja) * | 2008-02-27 | 2014-03-26 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤 |
| EP2324013B3 (en) | 2008-07-21 | 2014-10-22 | Purdue Pharma LP | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| WO2010102003A2 (en) * | 2009-03-03 | 2010-09-10 | Vanderbilt University | Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| AR078522A1 (es) * | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
| US9951038B2 (en) | 2012-12-27 | 2018-04-24 | Purdue Pharma L.P. | Quinazolin-4(3H)-one-type piperidine compounds and uses thereof |
| US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
| WO2014102594A2 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
| WO2014102590A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
| ES3014630T3 (en) | 2016-07-29 | 2025-04-23 | Janssen Pharmaceutica Nv | Niraparib for use in a method of treating prostate cancer |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1335831A (fr) * | 1962-10-09 | 1963-08-23 | Res Lab Dr C Janssen Nv | Procédé de préparation de nu-(3, 3-diphényl-3-alcanoyl)-propylspiro |
| US3161645A (en) | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
| US3318900A (en) | 1964-05-06 | 1967-05-09 | Janssen Pharmaceutica Nv | Derivatives of benzimidazolinyl piperidine |
| US3325499A (en) | 1964-11-02 | 1967-06-13 | Mcneilab Inc | 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone |
| US3666764A (en) * | 1970-08-26 | 1972-05-30 | Mead Johnson & Co | Spiroindenylpiperidines |
| DE2609645A1 (de) | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| US4329353A (en) | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
| US4410528A (en) | 1980-05-16 | 1983-10-18 | Kyowa Hakko Kogyo Co., Ltd. | Hypotensive piperidine derivatives |
| JPS58180481A (ja) | 1982-04-15 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| JPS60120872A (ja) | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
| EP0445974A3 (en) | 1990-03-05 | 1992-04-29 | Merck Sharp & Dohme Ltd. | Spirocyclic antipsychotic agents |
| DK78692D0 (da) | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| US5536716A (en) | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
| EP0681571B1 (en) | 1993-01-28 | 1998-07-29 | Merck & Co. Inc. | Spiro-substituted azacycles as tachykinin receptor antagonists |
| US5457207A (en) * | 1993-10-05 | 1995-10-10 | Regents Of The University Of Minnesota | Spirovesamicols |
| US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| AU688498B2 (en) | 1994-04-14 | 1998-03-12 | Merck & Co., Inc. | Alpha1c adrenergic receptor antagonists |
| FR2722190B1 (fr) | 1994-07-05 | 1996-10-04 | Sanofi Sa | Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant |
| US5767118A (en) | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
| US5574044A (en) | 1994-10-27 | 1996-11-12 | Merck & Co., Inc. | Muscarine antagonists |
| JPH11507670A (ja) | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
| CA2231773A1 (en) | 1995-09-13 | 1997-03-20 | Shigeru Aono | Phenylpiperidine derivative |
| US6180649B1 (en) | 1996-04-19 | 2001-01-30 | Nerosearch A/S | 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
| AU5604998A (en) | 1996-12-13 | 1998-07-03 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
| US6063796A (en) | 1997-04-04 | 2000-05-16 | Merck & Co., Inc. | Somatostatin agonists |
| ATE276242T1 (de) | 1997-05-30 | 2004-10-15 | Banyu Pharma Co Ltd | 2-oxoimidazol-derivate |
| JPH10330377A (ja) | 1997-06-02 | 1998-12-15 | Kyowa Hakko Kogyo Co Ltd | ピペリジン誘導体 |
| US6166037A (en) | 1997-08-28 | 2000-12-26 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
| GB9718833D0 (en) | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
| SI0921125T1 (en) | 1997-12-05 | 2002-04-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives |
| US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| US6013644A (en) * | 1997-12-12 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
| JP3342478B2 (ja) | 1998-01-19 | 2002-11-11 | ファイザー製薬株式会社 | Ｏｒｌ１−レセプターアゴニストとしての４−（２−ケト−１−ベンズイミダゾリニル）ピペリジン化合物 |
| BR9909666A (pt) | 1998-03-26 | 2001-09-11 | Japan Tobacco Inc | Derivados de amida e antagonistas de nociceptina |
| EP1080091A1 (en) | 1998-05-18 | 2001-03-07 | Novo Nordisk A/S | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| WO1999065494A1 (en) | 1998-06-15 | 1999-12-23 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ID29137A (id) | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| MA26659A1 (fr) | 1998-08-06 | 2004-12-20 | Pfizer | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. |
| JP2001011050A (ja) * | 1999-04-30 | 2001-01-16 | Sankyo Co Ltd | 含窒素飽和複素環化合物 |
| AU7716600A (en) | 1999-09-30 | 2001-04-30 | Merck & Co., Inc. | Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| SE9904652D0 (sv) | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| ATE413878T1 (de) | 2000-09-06 | 2008-11-15 | Ortho Mcneil Pharm Inc | Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen |
| AU2001288110A1 (en) * | 2000-09-27 | 2002-04-08 | Takeda Chemical Industries Ltd. | Spiro compounds |
-
2002
- 2002-04-18 JP JP2002582927A patent/JP4489354B2/ja not_active Expired - Fee Related
- 2002-04-18 EP EP02725733A patent/EP1385514B9/en not_active Expired - Lifetime
- 2002-04-18 AT AT02725733T patent/ATE413175T1/de active
- 2002-04-18 DK DK02725733T patent/DK1385514T5/da active
- 2002-04-18 PT PT02725733T patent/PT1385514E/pt unknown
- 2002-04-18 WO PCT/US2002/012357 patent/WO2002085354A1/en not_active Ceased
- 2002-04-18 DE DE60229736T patent/DE60229736D1/de not_active Expired - Lifetime
- 2002-04-18 AU AU2002256282A patent/AU2002256282C1/en not_active Ceased
- 2002-04-18 CA CA2443938A patent/CA2443938C/en not_active Expired - Fee Related
- 2002-04-18 SI SI200230789T patent/SI1385514T1/sl unknown
- 2002-04-18 US US10/126,472 patent/US6828440B2/en not_active Expired - Lifetime
- 2002-04-18 EP EP08168203A patent/EP2033644A1/en not_active Withdrawn
- 2002-04-18 ES ES02725733T patent/ES2316559T3/es not_active Expired - Lifetime
-
2009
- 2009-01-27 CY CY20091100103T patent/CY1108731T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532223A5 (enExample) | ||
| JP2004531531A5 (enExample) | ||
| JP2004531532A5 (enExample) | ||
| JP2005518330A5 (enExample) | ||
| CA2443938A1 (en) | Spiroindene and spiroindane compounds as opioid ligands useful for treating pain | |
| SU1138032A3 (ru) | Способ получени производных бициклического пиримидин-5-она или их солей с фармацевтически приемлемыми кислотами,или их цис- или транс-изомеров | |
| RU2003133454A (ru) | Аналоги ноцицептина | |
| RU2667907C9 (ru) | ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ | |
| CA2444489A1 (en) | Benzimidazolone compounds | |
| KR910019615A (ko) | 위산분비 억제 방법 | |
| PE20211703A1 (es) | Compuesto derivado heterotriciclico novedoso y uso del mismo | |
| CO5580770A2 (es) | Compuestos de quinolina terapeuticos con propiedades antagonistas de 5-ht | |
| HRP20150765T1 (hr) | Amid derivati piperidin- i piperazin-1-karboksilne kiseline te povezani spojevi kao modulatori amid hidrolaze masnih kiselina (faah) za lijeäśenje tjeskobe, boli i drugih stanja | |
| RU2444362C2 (ru) | Лекарственное средство | |
| CY1110382T1 (el) | Πυραζινο υποκατεστημενες αρυλοβενζοδιαζεπινες | |
| RU2001122727A (ru) | Амиды кислот, способ их получения и фармацевтическая композиция на их основе | |
| RU2004126612A (ru) | Хиназолиновые соединения | |
| AR028683A1 (es) | Derivados de 1,3,8-triaza-espiro[4.5]decan-4-ona | |
| JP2011137006A5 (enExample) | ||
| JP2004002414A5 (enExample) | ||
| DK110395A (da) | 1-Substituerede 4-(4-(lavere alkyl)sulfonylaminobenzoyl)-piperidiner, farmakologisk acceptable salte deraf samt farmaceutiske præparater med indhold af sådanne | |
| JP2005538062A5 (enExample) | ||
| RU2010111729A (ru) | Ингибиторы активности протеинтирозинкиназы | |
| RU2014115290A (ru) | Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов | |
| EP2313100B1 (en) | Inhibitors of the plasmodial surface anion channel as antimalarials |